Universe Pharmaceuticals INC
UPC · XNASCIK 1809616fmd_0WQE2PA9K9H8APJVA4KGTBNK40Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2018 to Sep 30, 2025, 11 periods
Latest annual · FY2025
Millions- Total revenues
- 17,859
- Gross profit
- 6,301
- Operating income
- (2,916)
- Net income
- (3,672)
- Free cash flow
- (5,319)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +663.4%
- Revenue, 5 yearsFY2020 to FY2025
- +257.2%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Universe Pharmaceuticals INC (UPC) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $17.9 billion | $23 billion | -22.4% | 20-F 2026-01-29 · proof |
| Gross profit | $6.3 billion | $6.1 billion | +3.8% | 20-F 2026-01-29 · proof |
| Operating income | -$2.9 billion | -$8 billion | 20-F 2026-01-29 · proof | |
| Net income | -$3.7 billion | -$8.7 billion | 20-F 2026-01-29 · proof | |
| Cash from operating activities | -$5.1 billion | -$9.5 billion | 20-F 2026-01-29 · proof | |
| Free cash flow | -$5.3 billion | -$9.7 billion | 20-F 2026-01-29 · proof | |
| Total assets | $69.3 billion | $68 billion | +2% | 20-F 2026-01-29 · proof |
| Total liabilities | $13.2 billion | $22.5 billion | -41.3% | 20-F 2026-01-29 · proof |
| Cash and cash equivalents | $33.6 billion | $29.5 billion | +13.9% | 20-F 2026-01-29 · proof |
- What was Universe Pharmaceuticals INC (UPC)'s revenue in fiscal 2025?
- Universe Pharmaceuticals INC (UPC) reported revenue of $17.9 billion for fiscal 2025 (the year ended Sep 30, 2025), against $23 billion the year before (-22.4%). Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
- What was Universe Pharmaceuticals INC (UPC)'s gross profit in fiscal 2025?
- Universe Pharmaceuticals INC (UPC) reported gross profit of $6.3 billion for fiscal 2025 (the year ended Sep 30, 2025), against $6.1 billion the year before (+3.8%). Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
- What was Universe Pharmaceuticals INC (UPC)'s operating income in fiscal 2025?
- Universe Pharmaceuticals INC (UPC) reported operating income of -$2.9 billion for fiscal 2025 (the year ended Sep 30, 2025), against -$8 billion the year before. Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
- What was Universe Pharmaceuticals INC (UPC)'s net income in fiscal 2025?
- Universe Pharmaceuticals INC (UPC) reported net income of -$3.7 billion for fiscal 2025 (the year ended Sep 30, 2025), against -$8.7 billion the year before. Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
- What was Universe Pharmaceuticals INC (UPC)'s cash from operating activities in fiscal 2025?
- Universe Pharmaceuticals INC (UPC) reported cash from operating activities of -$5.1 billion for fiscal 2025 (the year ended Sep 30, 2025), against -$9.5 billion the year before. Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
- What was Universe Pharmaceuticals INC (UPC)'s free cash flow in fiscal 2025?
- Universe Pharmaceuticals INC (UPC) reported free cash flow of -$5.3 billion for fiscal 2025 (the year ended Sep 30, 2025), against -$9.7 billion the year before. Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
- What are Universe Pharmaceuticals INC (UPC)'s total assets?
- As of Sep 30, 2025, Universe Pharmaceuticals INC (UPC) reported total assets of $69.3 billion, against $68 billion a year earlier (+2%). Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
- What are Universe Pharmaceuticals INC (UPC)'s total liabilities?
- As of Sep 30, 2025, Universe Pharmaceuticals INC (UPC) reported total liabilities of $13.2 billion, against $22.5 billion a year earlier (-41.3%). Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
- What are Universe Pharmaceuticals INC (UPC)'s cash and cash equivalents?
- As of Sep 30, 2025, Universe Pharmaceuticals INC (UPC) reported cash and cash equivalents of $33.6 billion, against $29.5 billion a year earlier (+13.9%). Source: the 20-F filed with the SEC on Jan 29, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:UPC&period_type=annual&limit=5"Information only, not investment advice.